Ai Kuzumi

Hongo, 1138655, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape.

Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape.

Journal: BMC immunology

Published: December 12, 2025

Usefulness of rituximab for the treatment of systemic sclerosis-associated interstitial lung disease: Further analysis of the DESIRES trial.

Usefulness of rituximab for the treatment of systemic sclerosis-associated interstitial lung disease: Further analysis of the DESIRES trial.

Journal: Journal of the American Academy of Dermatology

Published: November 15, 2024

Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial.

Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial.

Journal: Rheumatology (Oxford, England)

Published: October 21, 2024

A case of anti-CD320 antibody-positive cutaneous arteritis accompanied by multiple cranial nerve symptoms.

A case of anti-CD320 antibody-positive cutaneous arteritis accompanied by multiple cranial nerve symptoms.

Journal: Rheumatology (Oxford, England)

Published: September 24, 2024

The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review.

The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review.

Journal: American journal of clinical dermatology

Published: September 02, 2024

Autoantibody landscape and functional role of anti-C-C motif chemokine receptor 8 autoantibodies in systemic sclerosis: post-hoc analysis of a B-cell depletion trial.

Autoantibody landscape and functional role of anti-C-C motif chemokine receptor 8 autoantibodies in systemic sclerosis: post-hoc analysis of a B-cell depletion trial.

Journal: Nature communications

Published: August 05, 2024

Validation of Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score and establishment of novel score in Japanese patients with necrotizing fasciitis (J-LRINEC score).

Validation of Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score and establishment of novel score in Japanese patients with necrotizing fasciitis (J-LRINEC score).

Journal: The Journal of dermatology

Published: May 25, 2024

The Number of Nail Fold Capillaries and Nail Fold Bleedings Reflects the Clinical Manifestations of Systemic Sclerosis.

The Number of Nail Fold Capillaries and Nail Fold Bleedings Reflects the Clinical Manifestations of Systemic Sclerosis.

Journal: The Journal of investigative dermatology

Published: May 18, 2024

Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.

Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.

Journal: The Journal of dermatology

Published: April 01, 2024

Diversity and Epitope Spreading of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement.

Diversity and Epitope Spreading of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 25, 2024

Anti-Mi-2 antibody-positive dermatomyositis following Spirulina intake.

Anti-Mi-2 antibody-positive dermatomyositis following Spirulina intake.

Journal: Rheumatology (Oxford, England)

Published: February 24, 2024

Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review.

Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review.

Journal: Experimental dermatology

Published: January 25, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026